Tag: CBT > Cannabis DEA: Page 8

Interviews & Opinion

FDA Issues First Batch of Warning Letters to Delta-8 THC Product Manufacturers

The federal agency is warning five companies that they are marketing unapproved new drugs, misbranding their wares and unlawfully adding delta-8 THC to food products.

May 6, 2022

Finance

Justice Department to Return $1.1M in Cannabis-Related Cash to Armored Vehicle Company

Seized last year in San Bernardino County, Calif., the money came from licensed cannabis operators and will be returned to Empyreal Logistics.

April 14, 2022

Legislation and Regulation

U.S. House of Representatives Approves Medical Marijuana Research Act

The bipartisan legislation would allow researchers to access cannabis from state-legal dispensaries for their studies.

April 5, 2022

Compliance

Federally Approved Cannabis?

Pennsylvania-based Groff North America has begun growing DEA-approved cannabis for FDA clinical trials.

March 9, 2022

Hemp

HIA Supports Delta-8 Production, But Calls for Market Regulation

"Prohibition is a failed concept," the HIA said in a statement in conjunction with a legal opinion drafted by Kight Law.

June 23, 2021

Finance

Should Your Business Invest in Delta-8-THC?

While some businesses have successfully released Delta-8 brands, stakeholders still disagree on whether there's a market for these types of products.

March 22, 2021

Legislation and Regulation

UPDATE: What is Delta-8-THC?

It’s all the rage in some circles, but the decision on whether to make and market Delta-8-THC may be more complicated than it seems.

March 17, 2021

Legislation and Regulation

Industry Weighs in on DEA Cannabis Research Final Rule

Stakeholders express concern that the agency will weigh applicants’ compliance with federal law when granting registrations.

December 23, 2020

Legislation and Regulation

DEA Proposes New Hemp and CBD Regulations to Comply with 2018 Farm Bill

The DEA emphasizes the new rules are only to conform to the 2018 Farm Bill and have already taken effect.

August 21, 2020

Compliance

Newly Released Memo Finds DEA Not in Compliance with International Drug Laws

A 2018 memo concludes that the Drug Enforcement Administration must change its practices to comply with the Single Convention.

May 4, 2020